8-Time Winning Team Tour De France Doctor Reveals the ‘Champions Blueprint’ from Behind the Scenes of the 2011 Tour

Posted by & filed under Press Releases.

Press Releases concerning clinical trial results are intended to inform interested parties of the advancements of laser technology in process, not to imply new indications for use. Erchonia supports only those indications for use, cleared by the FDA via 510(k). ‘CHAMPIONS BLUEPRINT’ The “Ultimate Life Clinic” Teaches Anyone The Secrets To Becoming A Champion And… Read more »

Inside-Out Health: A Revolutionary Approach to Your Body (Advanced Seminar)

Posted by & filed under Press Releases.

Presented by: Dr. Robert Silverman November 19th-20th, 2016 – Indianapolis, IN Co-sponsored by: Erchonia Corporation & Northwestern Health Sciences University ~12 CE Hours Applied~  About the Seminar Join Dr. Silverman as he explores the process of implementing advanced laser protocols into your practice. He will share in-office tools, hands-on laser protocols, nutrition protocols and proven… Read more »

Nail Fungus Sufferers Find Relief in New Laser Treatment

Posted by & filed under Press Releases.

Lunula receives FDA approval, launches With the summer fun and flip flop season in full swing, those suffering from discolored toenails start to worry about wh at others think of their feet. Toenail fungus sufferers can now enjoy clear nail beds with the FDA 510(k) approval of the Lunula Laser, an Erchonia Corporation low-level laser…. Read more »

Erchonia Receives 7th FDA Market Clearance for Non Invasive Fat Loss

Posted by & filed under Press Releases.

Erchonia Receives 7th FDA Market Clearance for Non Invasive Fat Loss New once a week protocol allows for more treatment flexibility Erchonia announces today that they have received their 7th 510(k) market clearance and the 2nd in 2015 from the US FDA for non-invasive fat loss which is measured by circumference reduction. Erchonia has also been published 20… Read more »

Erchonia receives patent for noninvasive fat reduction.

Posted by & filed under Press Releases.

Patent no. US 8, 932,338B2- a noninvasive method of reducing fat from targeted regions of a patient’s body by applying low-level laser energy externally through the skin of the patient to the targeted areas. The laser works by applying sufficient energy to release intracellular fat into the interstitial space. The released intra-cellular fat is removed… Read more »

FDA Clears Erchonia’s New FX635 Laser for Chronic Heel Pain from Plantar Fasciitis

Posted by & filed under Press Releases.

“This new technology is a breakthrough for chronic heel pain sufferers, because it offers pain-free treatment with no known side effects or contraindications. “   Erchonia today announces the U.S. Food and Drug Administration (FDA) has granted the company 510 (k) clearance to market FX635, its new low level laser for the relief of chronic heel… Read more »

Results of Erchonia’s Lunula Laser’s Clinical Trial for the Noninvasive Treatment of Nail Fungus Published in Podiatry Review

Posted by & filed under Press Releases.

Erchonia today announces that the preliminary results of an ongoing clinical trial testing its Lunula laser for the noninvasive treatment of nail fungus have been published in the latest issue of the medical journal Podiatry Review.  “I am pleased to say the current data we are obtaining substantiates the Lunula laser as a safe and… Read more »

Erchonia Expands Presence in Europe with Erchonia Laser Ltd.

Posted by & filed under Press Releases.

Erchonia, the global leader in low level laser healthcareapplications, today announces the company is expanding with a London-based team, Erchonia Laser Ltd. This experienced management and sales team will handle European sales for all of Erchonia’s laser products including Zerona, Lunula, Verju, and the new XLR8 handheld device. Steven Shanks, president of Erchonia, comments, “We are excited to expand the Erchonia… Read more »

Erchonia XLR8 Laser Granted FDA Clearance for Pain Treatment

Posted by & filed under Press Releases.

Erchonia XLR8 Laser Granted FDA Clearance for Pain Treatment McKinney, TX – October 21, 2013 – Erchonia, the global leader in low level laser healthcare applications, today announces the company has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) to market its new XLR8 Laser for pain treatment. Depending on the settings… Read more »

Harvard Scientists Commend Erchonia for Excellence in Clinical Research for the Zerona Laser

Posted by & filed under Press Releases.

Tuesday, August 6th 2013 In the latest volume of the medical journal, Lasers in Surgery and Medicine, three Harvard scientists concluded that Erchonia’s research for its Zerona low-level laser device has, “set the precedent on how aesthetic devices should be evaluated.” McKinney, TX (PRWEB) August 06, 2013 In the latest volume of the medical journal,… Read more »